MedTrace Logo

Study on the Use of Inhaled NO (iNO)

NCT02821156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 239

Last updated 2016-07-01

No results posted yet for this study

Summary

This is a prospective, observational, multicenter study conducted during 1 year in adult and paediatric intensive care units equipped with the EZ-KINOX™ system.

A maximum of 250 patients (newborns to adults, suffering from Pulmonary Arterial Hypertension (PAH) associated with cardiac surgery or Persistent Pulmonary Hypertension in the Newborn (PPHN) receiving iNO through the integrated delivery and monitoring EZ-KINOX™ system was planned to be included.

The study is strictly non-interventional with the aim of describing current practices and therefore did not affect the patient usual management.

Conditions

  • Pulmonary Hypertension

Interventions

DRUG

Inhaled Nitric Oxide with monitoring by EZ-KINOX device

Sponsors & Collaborators

  • Euraxi Pharma

    collaborator INDUSTRY

  • Air Liquide Santé International

    lead INDUSTRY

Principal Investigators

  • Philippe POUARD, MD · Hôpital Necker-Enfants Malades

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-09-30
Completion
2015-10-31

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02821156 on ClinicalTrials.gov